Potential Targeted Therapy for Type I Diabetes: Monoclonal A

Innovative study on mice leads to a potential targeted monoclonal antibody therapy to manage Type I diabetes. Study highlights need for human version of antibody.

Related Keywords

United States , American , Devi Kasinathan , Zheng Guo , Dax Fu , Johns Hopkins University School Of Medicine , Surface Znt , Reverses Autoimmune Diabetes , Johns Hopkins Medicine , Drug Shelters Pancreas Cells , Immune System , New Experimental Drug , Johns Hopkins University School , Immune System Attack , Diabetes , Ancreas , Beta Cells , Onoclonal Antibodies , Targeted Therapy ,